| Recombinant human tgG molecules lacking Fc receptor I binding and monocyte triggering activities KL Armour, MR Clark, AG Hadley, LM Williamson European journal of immunology 29, 2613-2624, 1999 | 541 | 1999 |
| Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies KL Armour, HJ Hansen CA Patent 2,200,868, 2010 | 187* | 2010 |
| CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies HJ Hansen, KL Armour US Patent 5,874,540, 1999 | 187* | 1999 |
| Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies KL Armour, HJ Hansen WO Patent App. PCT/US1995/011,964, 1995 | 187* | 1995 |
| CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies KL Armour, HJ Hansen EP Patent App. 20,080,008,840, 1995 | 187* | 1995 |
| Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies KL Armour, JGJ van de Winkel, LM Williamson, MR Clark Molecular immunology 40 (9), 585-593, 2003 | 184 | 2003 |
| Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors AM Scott, D Geleick, M Rubira, K Clarke, EC Nice, FE Smyth, E Stockert, ... Cancer research 60 (12), 3254-3261, 2000 | 155 | 2000 |
| Specificity analysis of blood group Lewis-y (Le (y)) antibodies generatedagainst synthetic and natural Le (y) determinants K Kitamura, E Stockert, P Garin-Chesa, S Welt, KO Lloyd, KL Armour, ... Proceedings of the National Academy of Sciences 91 (26), 12957-12961, 1994 | 141 | 1994 |
| High affinity humanized anti-CEA monoclonal antibodies WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour US Patent App. 09/974,498, 2001 | 71* | 2001 |
| Developing recombinant HPA-1a–specific antibodies with abrogated Fcγ receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia C Ghevaert, DA Wilcox, J Fang, KL Armour, MR Clark, WH Ouwehand, ... The Journal of clinical investigation 118 (8), 2929-2938, 2008 | 68 | 2008 |
| High affinity humanized anti-CEA monoclonal antibodies WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour US Patent 6,333,405, 2001 | 66* | 2001 |
| Recombinant human anti-Lewis Y antibodies TP Wallace, KL Armour, FJ Carr, LJ Old, E Stockert, S Welt, K Kitamura, ... US Patent 6,310,185, 2001 | 66 | 2001 |
| High affinity humanized anti-CEA monoclonal antibodies WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour US Patent App. 09/974,051, 2001 | 66* | 2001 |
| HIGH AFFINITY HUMANIZED ANTI-CEA MONOCLONAL ANTIBODIES WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour EP Patent 1,056,859, 2000 | 66* | 2000 |
| HIGH AFFINITY HUMANIZED ANTI-CEA MONOCLONAL ANTIBODIES W ANDERSON, K Henry, P TEMPEST, F CARR, W HARRIS, K ARMOUR WO Patent 1,999,043,817, 1999 | 66* | 1999 |
| High affinity humanized anti-cea monoclonal antibodies WHK Anderson, K Armour, FJ Carr, WJ Harris, PR Tempest CA Patent App. 2,321,947, 1998 | 66* | 1998 |
| High affinity humanized anti-cea monoclonal antibodies WHK Anderson, K Armour, FJ Carr, WJ Harris, PR Tempest EP Patent App. 19,980,907,630, 1998 | 66* | 1998 |
| Fc Gamma Receptor 3A Polymorphism and Risk for HIV-Associated Cryptococcal Disease S Rohatgi, S Gohil, MH Kuniholm, H Schultz, C Dufaud, KL Armour, ... mBio 4 (5), e00573-13, 2013 | 65 | 2013 |
| Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells YS Goh, AJ Grant, O Restif, TJ McKinley, KL Armour, MR Clark, ... Immunology 133 (1), 74-83, 2011 | 62 | 2011 |
| CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies HJ Hansen, KL Armour EP Patent 1,736,163, 2010 | 62* | 2010 |
Mike ClarkRetired (30th Sept 2014) as Reader in Therapeutic and Molecular Immunology, Cambridge University在 cam.ac.uk 的电子邮件经过验证
Mike ClarkRetired (30th Sept 2014) as Reader in Therapeutic and Molecular Immunology, Cambridge University在 cam.ac.uk 的电子邮件经过验证